Core Viewpoint - The company has entered a strategic partnership with Silk Road Technology Co., Ltd. to promote cognitive impairment digital therapy products in Malaysia and Southeast Asia, addressing the growing demand for mental health solutions in the region [1][4]. Group 1: Partnership Details - The collaboration will focus on establishing a specialized laboratory for cognitive impairment digital therapy in Malaysia, with Silk Road assisting in local approvals and logistics while the company provides technical and research support [3]. - The partnership includes applying for national innovation pilot projects, with Silk Road leading the engagement with Malaysian authorities [3]. - Clinical pilot projects will be initiated in selected hospitals, with the company responsible for local adaptation, training, and data collection [3]. Group 2: Market Context - Malaysia faces challenges with an aging population and increasing mental health needs, with 3.8 million people aged 60 and above as of 2023 [1]. - The country has a significant shortage of mental health resources, with a counselor-to-population ratio of 1:52,000, far below the international standard of 1:500 [1]. Group 3: Strategic Importance - This partnership marks the company's official entry into the Malaysian market, expanding its Southeast Asian business network and leveraging its experience in the Chinese market [4]. - Silk Road's extensive local resources and networks will facilitate efficient product entry and market adaptation, enhancing commercial conversion rates [4]. - The collaboration aims to strengthen the company's brand authority in digital healthcare and accelerate the deployment of its products in local medical institutions [4].
脑动极光-B(06681)与丝路之舟订立战略合作协议 以拓展马来西亚市场及深化国际化布局